- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05988983
The Over The Counter Pill National Study
April 2, 2024 updated by: Maria Rodriguez, MD, MPH, Oregon Health and Science University
This is a prospective cohort study of individuals purchasing the oral contraceptive pill over the counter (OTC) in pharmacies in 32 US states.
The comparison group is people receiving a prescription (Rx) for oral contraception.
Both groups will be followed for one year to examine contraceptive continuation rates.
This study will also identify who is using the pill OTC and why and evaluate differences in pregnancy intention and measures of contraceptive agency between the two groups.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
900
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maria I Rodriguez, MD
- Phone Number: 503-494-7921
- Email: rodrigma@ohsu.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Individuals aged 12 to 51 who are obtaining the oral contraceptive pill at a pharmacy for the purposes of pregnancy prevention.
Description
Inclusion Criteria:
- Capable of pregnancy
- Purchasing oral contraception at a participating pharmacy
Exclusion Criteria:
- Using the pill for non contraceptive indications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
OTC users
Participants using the oral contraceptive pill purchased over the counter
|
Over the counter contraceptive pill
|
Rx users
Participants using the oral contraceptive pill received by a prescription
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
12 month contraceptive continuation rates
Time Frame: 12 months
|
Difference in proportion of participants using contraception 12 months after starting between over the counter and prescription groups.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2024
Primary Completion (Estimated)
October 1, 2025
Study Completion (Estimated)
October 1, 2025
Study Registration Dates
First Submitted
August 3, 2023
First Submitted That Met QC Criteria
August 3, 2023
First Posted (Actual)
August 14, 2023
Study Record Updates
Last Update Posted (Actual)
April 4, 2024
Last Update Submitted That Met QC Criteria
April 2, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OHSU IRB 14123
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
University of California, San FranciscoAgency for Healthcare Research and Quality (AHRQ); Essential Access HealthNot yet recruitingContraception | Contraception Behavior | Reproductive BehaviorUnited States
Clinical Trials on Availability of OTC contraceptive pill
-
University of Colorado, DenverCompletedContraception | Uterine HemorrhageUnited States
-
University of CambridgeOxford University Hospitals NHS Foundations TrustCompletedHealthy DietUnited Kingdom
-
University of LiverpoolCompletedObesity | Diet, Healthy | Food Selection | Eating BehaviorUnited Kingdom
-
Hacettepe UniversityCompleted
-
Federal University of Rio Grande do SulHospital de Clinicas de Porto Alegre; Coordenação de Aperfeiçoamento de Pessoal... and other collaboratorsCompletedPolycystic Ovary Syndrome
-
VA Office of Research and DevelopmentUniversity of UtahRecruiting
-
Eunice Kennedy Shriver National Institute of Child...TerminatedAmenorrhea | Aplastic Anemia | MenorrhagiaUnited States
-
University Hospital, GhentFund for Scientific Research, Flanders, BelgiumCompleted
-
Jeffrey JensenBill and Melinda Gates FoundationCompleted